Delivery Order SPE2DB22D9112-SPE2DB25FTKNK

Award Date 6/25/25
Potential Completion Date 7/17/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,603.85, is for the delivery of Mirena 52 mg Systems, a type of intrauterine contraceptive device. The contract has an ultimate completion date of April 4, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC)...
This firm-fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,960 contract is for the supply of Mirena 52 mg systems, a type of intrauterine contraceptive device. It was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 6, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC)...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,104.00 contract is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device. The contract has an ultimate completion date of November 26, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $24,996.96, is for the delivery of Mirena 52 mg systems, a type of intrauterine device. The contract has an ultimate completion date of April 4, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,960.00, is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device. The contract has an ultimate completion date of July 30, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA,...
This is a $1,562.31 firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract was awarded by the Defense Logistics Agency (DLA) to provide Mirena 52 mg systems, a type of intrauterine contraceptive device, with a period of performance through July 17, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,041.56 and an ultimate completion date of January 27, 2025. It covers the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,736 contract is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device. The contract has an ultimate completion date of November 29, 2024 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,552 contract is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device. The contract has an ultimate completion date of November 14, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,207.70, is for the delivery of Mirena 52 mg systems, a type of intrauterine device (IUD). The contract has an ultimate completion date of February 5, 2025. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a...
  • SPE2DB22D9112
    Indefinite Delivery Contract
  • SPE2DB22D9112-SPE2DB25FTKNK
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,041.56, is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device. The contract has an ultimate completion date of July 17, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that specializes in providing a comprehensive range of pharmaceutical products to federal agencies, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue firm fixed-price delivery orders for a wide variety of pharmaceutical items to support the medical supply needs of military health facilities worldwide.

Generated 9/24/25, 10:49 AM